To the Editor
DOCK8 deficiency is a highly morbid combined immunodeficiency that features recurrent sinopulmonary infections, viral skin infections, and severe food allergies.1,2 Hematopoietic stem cell transplantation (HSCT) cures infection susceptibility in DOCK8 deficiency.3–7 Whether HSCT also cures food allergy has not been systematically examined in humans.8 To gain insight into the etiopathogenesis of food allergy and its potential treatment, we studied food allergy in 12 DOCK8-deficient patients who underwent HSCT at the National Institutes of Health (NIH) Clinical Center.
First we retrospectively evaluated six patients who had received either matched related or unrelated donor cells following myeloablative conditioning (Patients 1–6 in Table 1) (see Methods in this article’s Online Repository).7 Of these, patients 2 and 4 reported histories of food-induced anaphylaxis before transplantation, and patient 5 reported a new food allergy after transplantation. Post-transplant, skin prick testing to eight common food allergens and specific IgE by ImmunoCAP confirmed sensitization to foods precipitating the reactions. Food challenges were not performed. A fourth patient (patient 1) reported oral pruritus to lentils before transplant and again when re-exposed more than one year after transplant. Donors in these cases were confirmed to have no history of food allergy.
Table 1.
Pre- and post- HSCT clinical food allergies, skin prick testing, and total serum IgE in the studied DOCK8-deficient patients.
| (Patient#) Age at HSCT |
Months after HSCT at most recent allergy evaluation |
Transplant Type^ |
GVHD prophylaxis type & duration of therapy after transplant |
Gut GVHD |
Clinical Food Allergies | Skin Prick Testing | Total Serum IgE (IU/mL) |
|||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Foods causing reaction pre- HSCT |
Foods causing reaction post- HSCT |
Symptoms with most severe reaction pre-HSCT |
Pre-HSCT Positive+ |
Post- HSCT Positive |
Peak Pre- HSCT |
Most Recent Post-HSCT |
||||||
| Patients studied retrospectively |
1 18yoF |
18 | MRD | Cyclosporine: 12 months |
Yes | Lentils | Lentils | Oral pruritus only | ND | ND | 8,031 | 870 |
|
2 10yoF |
23 | MRD | Tacrolimus: 8.5 months |
No | Egg, Milk, Wheat, Soy, Sesame, Tree Nuts |
Not Challenged | Anaphylaxis | ND | Egg, Milk, Wheat, Soy, Cashew (ND: Sesame) |
6,690 | 1,058 | |
|
3 23yoM |
21 | MRD | Tacrolimus: 14 months |
No | NONE | NONE | NONE | ND | ND | 51,010 | 153 | |
|
4 27yoM |
37 | URD | Tacrolimus: 11 months |
No | Peanut | Not Challenged | Anaphylaxis | ND | Peanut | 1,162 | 17.4 | |
|
5 25yoF |
24 | URD | Tacrolimus: 3 weeks then, Cyclosporine: 14 months |
No | NONE | Shrimp | Gastrointestinal symptoms only |
ND | Shrimp | 38.5 | 6.1 | |
|
6 16yoF |
18 | URD | Cyclosporine: 11 months |
No | NONE | NONE | NONE | ND | ND | 180 | 9.4 | |
| Patients studied prospectively | 7 19yoM |
12 | URD | Tacrolimus: 9 months |
No | Egg: resolved in early childhood, Tree Nuts persisted |
Egg, No Tree Nut exposure |
Anaphylaxis | -- Walnut Cashew |
Egg Walnut -- |
6,398 | 1,224 |
|
8* 21yoM |
Died | URD | Tacrolimus: ongoing |
Yes | Milk, Egg, Peanut | Not challenged | Anaphylaxis | Milk, Egg, Peanut, Shrimp |
ND | 31,403 | 627 | |
|
9 20yoF |
12 | haplo | Tacrolimus: 6 months |
No | Egg, milk, wheat, peanut, cashew |
Egg/milk, No exposures to others |
Anaphylaxis | Egg, Wheat, Peanut, Cashew |
Egg, Wheat, Peanut, Cashew |
6,905 | 67.8 | |
|
10 13yoM |
10 | MRD | Tacrolimus: 7 months |
No | Egg, Wheat, Peanut, Kiwi, Banana |
Not challenged | Anaphylaxis | Egg, Wheat, Peanut |
Egg, Wheat, Peanut |
>6,000 | 915 | |
|
11 9yoF |
6 | URD | Tacrolimus: ongoing |
Yes | NONE | NONE | NONE | NONE | NONE | 2.0 | 2.9 | |
|
12 19yoF |
3 | haplo | Tacrolimus: ongoing |
No | Kiwi, concentrated milk, concentrated egg |
Kiwi, No exposure to others |
Oral angioedema and pruritus |
Milk, Egg, Cashew (Kiwi not done) |
-- Egg, -- Kiwi |
>6,000 | 594 | |
MRD=Matched Related Donor, URD=Unrelated Donor, haplo=haploidentical
Skin prick testing was performed for the following common food allergens: milk, egg, soy, wheat, peanut, walnut, cashew, shrimp for each patient pre- and post- HSCT unless otherwise indicated. All positive results are listed. − Negative result. ND: Not done.
Patient died prior to 3 months post-transplant; no follow up skin prick testing was performed.
Our observations of persisting or new food allergies were unexpected given anecdotal reports suggesting that HSCT cured food allergies, which could have reflected a selection bias.4,5,9 Thus, we prospectively studied food allergies in the next six DOCK8-deficient patients transplanted at the NIH (Patients 7–12 in Table 1). This second group included two patients (patients 9 and 12) who had undergone related donor haploidentical transplants and had systemic allergic reactions to foods that they were already allergic to before transplant. Donors were confirmed to have no history of food allergy. Patient 9 was more than eight months after HSCT and more than two months off tacrolimus when she developed acute oral and facial angioedema, diffuse urticaria, vomiting, and difficulty breathing within minutes of eating oatmeal fortified with egg and milk. Her symptoms resolved after receiving epinephrine, diphenhydramine, and methylprednisolone. Prior to transplantation, she had had anaphylactic reactions to egg and milk. However, two months before her last reaction, her skin prick testing was positive to egg but not milk, suggesting egg as the culprit (see Table E1 in this article’s Online Repository). Similarly, patient 12 was 45 days out after HSCT when she developed oral and periorbital angioedema and diffuse urticaria and pruritus within 10 minutes of eating a kiwi fruit, with sensitization confirmed by skin prick testing (Table 1; and Table E1 in this article’s Online Repository). Years prior to transplant she too had had oral pruritus and lip angioedema after eating kiwi and had subsequently avoided it entirely.
Among the patients studied prospectively, a third patient who underwent matched unrelated donor transplantation reported that a previously resolved food allergy had returned. Patient 7 was three months out of HSCT when he developed cramping abdominal pain, vomiting, diarrhea, and headache within 15 minutes of eating scrambled eggs. His symptoms occurred on two more occasions, but never when he ate baked eggs. He had had similar symptoms in his early school age years but had been eating eggs freely for the decade prior to transplant. Skin prick testing confirmed that he had acquired new reactivity to egg after transplantation (Table 1; and see Table E1 in this article’s Online Repository). The donor was confirmed to have no history of food allergy. Patient 7 also had a history of anaphylaxis to walnut as recently as three years prior to HSCT. Because of persisting positive skin prick testing, he continued to strictly avoid tree nuts after transplantation.
We observed that total serum IgE levels plummeted after HSCT but remained high in most patients (Figure 1). Food-specific IgE levels also remained high for months after transplant in several patients, even at levels with >95% positive predictive value for clinical food reactivity for some (see Table E2 in this article’s Online Repository). Moreover, skin prick testing revealed persisting mast cell reactivity to food allergens, which seemed to correlate best with the anaphylactic episode described post-transplant in patient 9 (see Table E1 in this article’s Online Repository). Persistence of allergen sensitization occurred regardless of donor type. The possibility of long-lived, host-derived, IgE-producing plasma cells in the bone marrow could explain allergy persistence. Indeed, we observed that bone marrow chimerism approached but did not reach 100% (see Table E3 in this article’s Online Repository).
Figure 1.
Total serum IgE in DOCK8-deficient patients after HSCT. Symbols used to represent patients: patient 1, blue-filled circle; patient 2, red-filled square; patient 3, green-filled triangle; patient 4, purple-filled triangle; patient 5, orange-filled diamond; patient 6, black-filled circle; patient 7, brown-filled square; patient 8, open yellow circle; patient 9, navy-filled triangle; patient 10, burgundy-filled diamond; patient 11, open blue circle; patient 12, green asterisk.
Although HSCT in DOCK8-deficient patients is now considered standard of care, its outcome for food allergy remains less clear. In two DOCK8-deficient patients who had full donor chimerism after HSCT, food allergies were only mentioned as having resolved.4,5 In another DOCK8-deficient patient with full donor chimerism after HSCT, multiple undescribed food allergies resolved while lentil allergy (the only one to cause anaphylaxis in this patient) persisted and total IgE levels remained abnormally high.6 In a fourth patient who had mixed donor peripheral blood chimerism (53% mononuclear cells, 6% granulocytes, 98% T-cells, 35% B-cells), multiple food allergies persisted although they were less severe.3 By contrast, all of our patients who had food allergy reactions after transplantation had 100% peripheral blood donor chimerism (see Table E3 in this article’s Online Repository).
Our study is limited in that we did not perform double blind placebo-controlled food challenges before and after HSCT. However, the two systemic reactions (patients 9 and 12) and one local reaction (patient 1) to foods that had previously caused reactions prior to transplant strongly support persistence of food allergy in these three patients. Tacrolimus has been associated with new-onset food allergy after solid organ transplantation.10 Although its use in our patient cohort could have contributed to some of the allergy we observed, this seemed unlikely in two patients. Patient 1 received only cyclosporine for graft versus host disease (GVHD) prophylaxis. Patient 5 received tacrolimus for only three weeks before it was switched to cyclosporine. Furthermore, in no previous reports of persisting allergies did DOCK8-deficient patients receive tacrolimus3,6.
Our case series describes what is to our knowledge the first systematic study of food allergy in HSCT, which may have implications for understanding food allergy more broadly in patients who do not have DOCK8 deficiency. We have observed that food allergy is not always cured after HSCT, at least not initially, even when 100% peripheral blood donor chimerism is achieved. Thus, strict food avoidance diets should continue to be followed until appropriate allergy testing and medically supervised food challenges can be performed. The overall trends toward decreasing total IgE, decreasing food-specific IgE, and decreasing skin wheal sizes, together suggest that these patients may have an increased probability to eventually outgrow their food allergies than their food allergic peers who have not been transplanted. Long-term follow up of these patients will be informative.
Corinne S. Happel, MD
Kelly D. Stone, MD, PhD
Alexandra F. Freeman, MD
Nirali N. Shah, MD
Angela Wang, RN
Jonathan J. Lyons, MD
Pamela A. Guerrerio, MD, PhD
Dennis D. Hickstein, MD
Helen C. Su, MD, PhD
Supplementary Material
Acknowledgments
Funding sources
We thank Avanti Desai for technical assistance; Huie Jing and Julie Niemela for DNA sequencing; Thomas Dimaggio, Stephanie Cotton, Cindy Delbrook, Sherri DePollar, and Terri Moore for clinical support; Qian Zhang and Ahmet Ozen for critically reading the manuscript and helpful discussions; and the patients for participating in this research study.
This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases and National Cancer Institute. This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.
Abbreviations used
- CGH
comparative genomic hybridization
- F
female
- GVHD
graft versus host disease
- Haplo
haploidentical donor
- HSCT
hematopoietic stem cell transplantation
- IgE
immunoglobulin E
- M
male
- MRD
matched related donor
- ND
not done
- NIH
National Institutes of Health
- URD
unrelated donor
- yo
year old
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
The authors have no conflicting financial interests.
References
- 1.Zhang Q, Davis JC, Lamborn IT, et al. Combined immunodeficiency associated with DOCK8 mutations. The New England journal of medicine. 2009;361:2046–2055. doi: 10.1056/NEJMoa0905506. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Aydin SE, Kilic SS, Aytekin C, et al. DOCK8 Deficiency: Clinical and Immunological Phenotype and Treatment Options - a Review of 136 Patients. Journal of clinical immunology. 2015 doi: 10.1007/s10875-014-0126-0. [DOI] [PubMed] [Google Scholar]
- 3.Bittner TC, Pannicke U, Renner ED, et al. Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation. Klinische Padiatrie. 2010;222:351–355. doi: 10.1055/s-0030-1265135. [DOI] [PubMed] [Google Scholar]
- 4.Barlogis V, Galambrun C, Chambost H, et al. Successful allogeneic hematopoietic stem cell transplantation for DOCK8 deficiency. The Journal of allergy and clinical immunology. 2011;128:420–422. e2. doi: 10.1016/j.jaci.2011.03.025. [DOI] [PubMed] [Google Scholar]
- 5.Boztug H, Karitnig-Weiss C, Ausserer B, et al. Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen. Pediatric hematology and oncology. 2012;29:585–594. doi: 10.3109/08880018.2012.714844. [DOI] [PubMed] [Google Scholar]
- 6.Metin A, Tavil B, Azik F, et al. Successful bone marrow transplantation for DOCK8 deficient hyper IgE syndrome. Pediatric transplantation. 2012;16:398–399. doi: 10.1111/j.1399-3046.2011.01641.x. [DOI] [PubMed] [Google Scholar]
- 7.Cuellar-Rodriguez J, Freeman AF, Grossman J, et al. Matched Related and Unrelated Donor Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 doi: 10.1016/j.bbmt.2015.01.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Khan F, Hallstrand TS, Geddes MN, Henderson WR, Jr, Storek J. Is allergic disease curable or transferable with allogeneic hematopoietic cell transplantation? Blood. 2009;113:279–290. doi: 10.1182/blood-2008-01-128686. [DOI] [PubMed] [Google Scholar]
- 9.Hourihane JO, Rhodes HL, Jones AM, Veys P, Connett GJ. Resolution of peanut allergy following bone marrow transplantation for primary immunodeficiency. Allergy. 2005;60:536–537. doi: 10.1111/j.1398-9995.2005.00752.x. [DOI] [PubMed] [Google Scholar]
- 10.Frischmeyer-Guerrerio PA, Wisniewski J, Wood RA, Nowak-Wegrzyn A. Manifestations and long-term outcome of food allergy in children after solid organ transplantation. The Journal of allergy and clinical immunology. 2008;122:1031–1033. e1. doi: 10.1016/j.jaci.2008.08.032. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.

